In the Senate of the United States, 
December 1, 2022. 
Resolved, That the bill from the House of Representa-
tives (H.R. 1193) entitled ‘‘An Act to amend title IV of the 
Public Health Service Act to direct the Director of the Na-
tional Institutes of Health, in consultation with the Director 
of the National Heart, Lung, and Blood Institute, to estab-
lish a program under which the Director of the National In-
stitutes of Health shall support or conduct research on val-
vular heart disease, and for other purposes.’’, do pass with 
the following 
AMENDMENT: 
Strike all after the enacting clause and insert the 
following: 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Cardiovascular Ad-
vances in Research and Opportunities Legacy Act’’. 
SEC. 2. HHS VALVULAR HEART DISEASE ACTIVITIES. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (referred to in this section as the ‘‘Sec-
† HR 1193 EAS 
retary’’) shall, as appropriate, continue activities related 
to research, education, and awareness of valvular heart dis-
eases. 
(b) NIH RESEARCH RELATED TO VALVULAR HEART 
DISEASES.— 
(1) IN GENERAL.—The Director of the National 
Institutes of Health, in consultation with the Director 
of the National Heart, Lung, and Blood Institute, 
may support or conduct research regarding valvular 
heart diseases. 
(2) SUPPORT FURTHER RESEARCH.—In order to 
improve information on, and understanding of, cau-
sation and risk factors for valvular heart diseases, re-
search conducted or supported under this subsection 
for such diseases may include the following: 
(A) Use of advanced technological imaging 
and other relevant methods to generate data re-
lated to valvular heart diseases. 
(B) Assessing potential risk factors for sud-
den cardiac arrest or sudden cardiac death from 
valvular heart diseases. 
(C) Other activities, as appropriate, in 
order to improve the availability of information 
on, and advance research related to, valvular 
heart diseases.
† HR 1193 EAS 
(3) MITRAL VALVE PROLAPSE WORKSHOP.—Not 
later than 2 years after the date of enactment of this 
Act, the Director of the National Heart, Lung, and 
Blood Institute shall, as appropriate, convene a work-
shop composed of subject matter experts and stake-
holders to identify research needs and opportunities to 
develop recommendations for the identification and 
treatment of individuals with mitral valve prolapse, 
including such individuals who may be at risk for 
sudden cardiac arrest or sudden cardiac death. 
(c) PREVENTION ACTIVITIES TO IMPROVE AWARENESS 
OF SUDDEN CARDIAC DEATH AS A RESULT OF VALVULAR 
HEART DISEASES.— 
(1) IN GENERAL.—The Secretary may carry out 
activities to increase education and awareness of val-
vular heart diseases in order to reduce the incidence 
of sudden cardiac death caused by such diseases. The 
Secretary may— 
(A) award grants or contracts to public or 
nonprofit private entities to carry out activities 
under this subsection; and 
(B) directly, or through grants or contracts, 
provide technical assistance with respect to such 
activities.
† HR 1193 EAS 
(2) CERTAIN ACTIVITIES.—Upon availability of 
applicable data, projects carried out under paragraph 
(1) may include— 
(A) continuing activities at the Centers for 
Disease Control and Prevention related to val-
vular heart diseases; 
(B) improving the awareness of the public 
concerning any risk factors for, the symptoms of, 
and the public health impact of, valvular heart 
diseases; and 
(C) enhancing public health data collection 
and improving the quality of such data, as ap-
propriate, regarding cardiac arrests, including 
cardiac arrests that occur outside of the hospital. 
(3) GRANT
PRIORITIZATION.—The Secretary 
may, in awarding grants or entering into contracts 
pursuant to paragraph (1), give priority to entities 
seeking to carry out projects for populations most im-
pacted by valvular heart diseases. 
(4) COORDINATION
OF
ACTIVITIES.—The Sec-
retary shall, as appropriate, ensure that activities 
under this section are coordinated with other agencies 
and offices of the Department of Health and Human 
Services that carry out activities regarding valvular 
heart diseases.
† HR 1193 EAS 
(5) BEST PRACTICES.—The Secretary shall, as 
applicable and appropriate, identify and disseminate 
best practices for relevant health care providers re-
lated to valvular heart diseases. 
(d) AUTHORIZATION OF APPROPRIATIONS.—For pur-
poses of carrying out this section, there are authorized to 
be appropriated $28,000,000 for each of fiscal years 2023 
through 2027. 
Attest: 
Secretary.